当前位置:主页 > 医学论文 > 药学论文 >

肾上腺髓质素受体信号活动参与吗啡耐受的细胞学机制—对胶质细胞的激活

发布时间:2018-08-31 13:04
【摘要】:肾上腺髓质素(adrenomedullin, AM)是降钙素基因相关肽(calcitonin gene related peptide, CGRP)家族的一员,与CGRP具有相似的功能。AM在脊髓背角浅层和背根神经节感觉神经元都有表达,是一种疼痛相关肽。最近的研究发现,慢性应用吗啡,通过μ-阿片受体和蛋白激酶C信号通路导致AM表达上调,引起吗啡耐受,鞘内注射AM受体拮抗剂AM22-52可翻转吗啡耐受。这一结果提示,AM参与了吗啡耐受的形成。但是其促进吗啡耐受的细胞学机制尚不清楚。为揭示AM参与吗啡耐受的细胞学机制。本研究通过在体和离体实验,分别采用AM受体拮抗剂和AMsiRNA抑制AM受体,观察阻断AM受体功能后,慢性应用吗啡诱导的胞内痛介导质兴奋性氨基酸和促炎性细胞因子的变化。并采用行为学、实时荧光定量PCR、蛋白印迹、免疫荧光组化等技术研究AM调节促炎性细胞因子的细胞学机制,揭示AM参与吗啡耐受的机制。 结果显示:(1)鞘内给予AM受体拮抗剂AM22-52(10nmol),能抑制吗啡耐受大鼠脊髓背角和血浆中兴奋性氨基酸(谷氨酸和天门冬氨酸)释放增加,还能抑制脊髓背角中促炎性细胞因子IL-1β、IL-6mRNA表达增加。(2) AM siRNA (50nM)干扰离体培养的DRG外植体,能抑制慢性应用吗啡(3.3μM)诱导的DRG外植体中促炎性细胞因子IL-1β、IL-6mRNA表达增加。(3)单独连续7天鞘内注射AM受体激动剂AM1-50(10μg),能引起大鼠脊髓背角中IL-1β、IL-6和TNF-α mRNA表达增加,却引起DRG中IL-1β、IL-6和TNFα mRNA表达下降。(4)单独连续7天鞘内注射AM1-50,能引起脊髓背角星型胶质细胞和小胶质细胞特异性标志物GFAP和OX-42表达增加;而鞘内注射AM22-52,能抑制慢性应用吗啡诱导的大鼠脊髓背角GFAP和OX-42表达增加。(5)免疫荧光双重染色显示在大鼠脊髓背角中AM受体的结合部件CRLR和RAMP2与小胶质细胞标志物OX-42共表达。(6)连续7天鞘内注射AM1-50,可引起脊髓背角磷酸化p38蛋白表达增加;鞘内联合注射小胶质细胞选择性抑制剂米诺环素可抑制慢性应用AM1-s0诱发的痛觉过敏,抑制p38磷酸化水平增加,抑制促炎性细胞因子IL-1β、IL-6、TNF-α mRNA表达增加。 以上结果表明:AM受体通过调节兴奋性氨基酸(谷氨酸和天门冬氨酸)和促炎性因子IL-1β、IL-6和TNF-α合成参与吗啡耐受。AM受体通过直接方式引起星型胶质细胞和小胶质激活,促使其增加IL-1β、IL-6和TNF-α合成,引起吗啡耐受。其作用机制之一是通过小胶质细胞p38MAPK信号通路介导。
[Abstract]:Adrenomedullin (adrenomedullin, AM) is a member of calcitonin gene-related peptide (calcitonin gene related peptide, CGRP) family. It has similar function with CGRP. AM is expressed in the sensory neurons of dorsal horn and dorsal root ganglion. It is a kind of pain related peptide. Recent studies have found that chronic morphine administration through 渭 -opioid receptor and protein kinase C signaling pathway leads to upregulation of AM expression, leading to morphine tolerance, and intrathecal injection of AM receptor antagonist AM22-52 can reverse morphine tolerance. These results suggest that AM is involved in the development of morphine tolerance. However, the cytological mechanism for promoting morphine tolerance is unclear. To elucidate the cytological mechanism of AM involved in morphine tolerance. In this study, in vivo and in vitro, AM receptor antagonists and AMsiRNA were used to inhibit AM receptor, respectively. After blocking the function of AM receptor, the changes of intracellular excitatory amino acids and pro-inflammatory cytokines induced by morphine were observed. The cytological mechanism of AM regulating pro-inflammatory cytokines was studied by means of behavioral, real-time fluorescent quantitative PCR, Western blotting and immunofluorescence histochemistry, and the mechanism of AM involved in morphine tolerance was revealed. The results showed that: (1) intrathecal administration of AM receptor antagonist AM22-52 (10nmol) inhibited the increased release of excitatory amino acids (glutamate and aspartate) in spinal dorsal horn and plasma of morphine tolerant rats. It also inhibited the expression of pro-inflammatory cytokine IL-1 尾 -mil 6 mRNA in spinal dorsal horn. (2) AM siRNA (50nM) interfered with DRG explants cultured in vitro. The expression of pro-inflammatory cytokine (IL-1 尾) and IL-6 mRNA in DRG explants induced by chronic morphine administration (3.3 渭 M) was inhibited. (3) Intrathecal injection of AM receptor agonist AM1-50 (10 渭 g),) alone for 7 days could increase the expression of IL-1 尾 IL-6 and TNF- 伪 mRNA in the dorsal horn of spinal cord of rats. However, the expression of IL-1 尾 -IL-6 and TNF 伪 mRNA decreased in DRG. (4) Intrathecal injection of AM1-50, alone for 7 days increased the expression of GFAP and OX-42, the specific markers of astrocyte and microglia in the dorsal horn of spinal cord. Intrathecal injection of AM22-52, inhibited the increase of GFAP and OX-42 expression in the spinal dorsal horn of rats induced by chronic morphine. (5) Immunofluorescence double staining showed that CRLR and RAMP2, the binding components of AM receptor, and microglia markers in the dorsal horn of spinal cord of rats. (6) Intrathecal injection of AM1-50, for 7 days increased the expression of phosphorylated p38 protein in the dorsal horn of spinal cord. Intrathecal injection of minocycline, a selective microglia inhibitor, could inhibit hyperalgesia induced by chronic AM1-s0, increase the level of p38 phosphorylation, and inhibit the expression of pro-inflammatory cytokine IL-1 尾, IL-6, TNF- 伪 mRNA. These results suggest that the receptor of 1: AM participates in the activation of astrocytes and microglia by regulating the synthesis of excitatory amino acids (glutamic acid and aspartic acid) and the pro-inflammatory factors IL-1 尾, IL-6 and TNF- 伪. It increased the synthesis of IL-1 尾 -IL-6 and TNF- 伪 and induced morphine tolerance. One of its mechanisms is mediated by microglial p38MAPK signaling pathway.
【学位授予单位】:福建师范大学
【学位级别】:博士
【学位授予年份】:2014
【分类号】:R96

【共引文献】

相关期刊论文 前10条

1 安兰敏;牛玉杰;徐兵;刘纳;;铅对大鼠脑细胞凋亡的诱发作用及对fos、jun、p53基因和一氧化氮合酶表达的影响[J];癌变.畸变.突变;2006年05期

2 孔丽娜,杨军文,汪秀娟,丁华峰,胡红珍;妊高征患者血浆一氧化氮、超氧化物歧化酶和过氧化脂质的变化[J];安徽医学;2001年03期

3 陈伟良,曾曙光,李海刚,黄洪章,潘朝斌;舌鳞癌组织iNOSmRNA表达及其意义[J];癌症;2002年03期

4 李海刚,潘朝斌,曾弘,曾韵洁,沈溪明,董书X;一氧化氮合酶mRNA和蛋白在骨巨细胞瘤中的表达及意义[J];癌症;2003年11期

5 王晓安,郑哲民;河北环毛蚓神经系统一氧化氮合酶的组织化学定位[J];动物学杂志;2002年02期

6 王晓安,蒋小满,郑哲民;软体动物的一氧化氮及其合酶的研究进展[J];动物学杂志;2003年06期

7 武桂新,王枫,吴云娥,冯炜权;运动与骨骼肌内一氧化氮[J];北京体育大学学报;1999年03期

8 孙红梅;;不同运动负荷对大鼠心肌超微结构及一氧化氮与一氧化氮合酶的影响[J];北京体育大学学报;2008年07期

9 尚玢;;耐力训练对Ⅱ型糖尿病患者NO和NOS的影响[J];北京体育大学学报;2008年12期

10 刘艳,余华峰,刘玉军,宋晓红,徐庆中,冯景阳,耿稚萍,张勇,鲁志达;7-硝基吲唑对大鼠局部脑缺血急性期保护作用的研究[J];北京医学;2001年02期

相关会议论文 前9条

1 朱翠凤;李艳飞;彭宏斌;刘桂琴;陆红;郭松超;张帆;李勇;;海洋胶原肽对2型糖尿病大鼠血清SOD、GSH、MDA及NO表达的影响[A];膳食营养、身体活动与健康——达能营养中心第十一次学术年会会议论文集[C];2008年

2 朱翠凤;李艳飞;彭宏斌;刘桂琴;陆红;郭松超;张帆;李勇;;海洋胶原肽对2型糖尿病大鼠血清SOD、GSH、MDA及NO表达的影响[A];营养与食品——健康中国高级论坛Ⅱ论文集[C];2008年

3 王月丽;;一氧化氮、骨骼肌与运动[A];2007全国运动生理学论文报告会论文集[C];2007年

4 王月丽;周越;高晓娟;王瑞元;;低氧运动后不同恢复环境下大鼠腓肠肌NOS和NO的变化[A];2007全国运动生理学论文报告会论文集[C];2007年

5 曾昭书;廖志钢;陈昆峰;李秀清;;NMDA-Ca~(2+)—NO路径与脑损伤及其法医学应用[A];中国法医学最新科研与实践(一)——全国第六次法医学术交流会论文精选[C];2000年

6 王延丽;石晋丽;赵保胜;;焦虑症的发生机制研究进展[A];中华中医药学会第十届中药鉴定学术会议暨WHO中药材鉴定方法和技术研讨会论文集[C];2010年

7 丁明玉;王菲菲;王先良;钱岩;;燃煤PM_(2.5)对血管内皮细胞EA.hy926释放NO的影响[A];2012中国环境科学学会学术年会论文集(第三卷)[C];2012年

8 胡爱民;;2型糖尿病并非酒精性脂肪肝研究近况[A];第十四次全国中医糖尿病大会论文集[C];2012年

9 郑少雄;刘新胜;单春艳;;骨质疏松发生机理的进展[A];第八届全国骨质疏松年会暨第五届全国钙剂年会会议文集[C];2002年



本文编号:2215073

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2215073.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户fbdd4***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com